CorVel Co. (NASDAQ:CRVL) Shares Bought by Invesco Ltd.

Invesco Ltd. increased its position in CorVel Co. (NASDAQ:CRVL) by 225.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 284,766 shares of the business services provider’s stock after buying an additional 197,358 shares during the quarter. Invesco Ltd. owned about 0.56% of CorVel worth $31,683,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of CRVL. Fifth Third Bancorp raised its position in CorVel by 45.9% in the fourth quarter. Fifth Third Bancorp now owns 321 shares of the business services provider’s stock worth $36,000 after acquiring an additional 101 shares in the last quarter. Sanctuary Advisors LLC grew its stake in shares of CorVel by 4.6% in the 3rd quarter. Sanctuary Advisors LLC now owns 2,848 shares of the business services provider’s stock worth $931,000 after purchasing an additional 124 shares during the last quarter. Franklin Resources Inc. raised its holdings in shares of CorVel by 9.9% in the 3rd quarter. Franklin Resources Inc. now owns 1,917 shares of the business services provider’s stock worth $614,000 after purchasing an additional 173 shares in the last quarter. US Bancorp DE lifted its stake in CorVel by 225.4% during the fourth quarter. US Bancorp DE now owns 384 shares of the business services provider’s stock valued at $43,000 after purchasing an additional 266 shares during the last quarter. Finally, GAMMA Investing LLC boosted its holdings in CorVel by 175.2% during the fourth quarter. GAMMA Investing LLC now owns 432 shares of the business services provider’s stock worth $48,000 after buying an additional 275 shares in the last quarter. Institutional investors own 51.36% of the company’s stock.

Insiders Place Their Bets

In other CorVel news, CFO Brandon O’brien sold 1,523 shares of the firm’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $119.56, for a total transaction of $182,089.88. Following the completion of the sale, the chief financial officer now directly owns 17,142 shares in the company, valued at approximately $2,049,497.52. This trade represents a 8.16 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Steven J. Hamerslag sold 10,000 shares of the company’s stock in a transaction dated Thursday, February 6th. The shares were sold at an average price of $123.48, for a total value of $1,234,800.00. Following the completion of the transaction, the director now owns 314,000 shares in the company, valued at $38,772,720. This represents a 3.09 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 48,723 shares of company stock worth $5,757,140. Corporate insiders own 47.57% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com upgraded CorVel from a “hold” rating to a “buy” rating in a research report on Friday.

CorVel Stock Down 1.7 %

Shares of NASDAQ CRVL opened at $115.09 on Friday. CorVel Co. has a 12 month low of $76.20 and a 12 month high of $128.61. The company has a market cap of $5.91 billion, a price-to-earnings ratio of 67.70 and a beta of 0.94. The business has a fifty day simple moving average of $111.25 and a 200-day simple moving average of $115.24.

CorVel (NASDAQ:CRVL) last posted its quarterly earnings data on Tuesday, February 4th. The business services provider reported $0.46 EPS for the quarter. CorVel had a net margin of 10.12% and a return on equity of 32.22%.

CorVel Company Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.